The global impact of the Gynecologic Cancer InterGroup in enhancing clinical trials in ovarian cancer

• Published in: International journal of gynecological cancer Vol. 21; no. 4; pp. 746 - 749
• Main Authors: Bacon, Monica, Kitchener, Henry, Stuart, Gavin C E, Vermorken, Jan B
• Format: Journal Article
• Language: English
• Published: England BMJ Publishing Group LTD 01.05.2011
• Subjects: Carcinoma - therapy; Clinical trials; Clinical Trials as Topic - methods; Clinical Trials as Topic - standards; Clinical Trials as Topic - trends; Consensus; Female; Gynecology - legislation & jurisprudence; Gynecology - methods; Gynecology - organization & administration; Gynecology - trends; Humans; International Agencies - organization & administration; International Cooperation; Medical Oncology - legislation & jurisprudence; Medical Oncology - methods; Medical Oncology - organization & administration; Medical Oncology - trends; Ovarian cancer; Ovarian Neoplasms - therapy; Societies, Medical - organization & administration
• ISSN: 1048-891X; 1525-1438
• DOI: 10.1097/IGC.0b013e31821bb446

The Gynecologic Cancer InterGroup (GCIG) has developed from a small network of ovarian cancer researchers to a large international forum addressing multiple issues related to research in gynecologic cancers. Member groups of the GCIG have collaboratively conducted pivotal clinical trials in cancers of the ovary, endometrium, and cervix. The participation of operational and statistical personnel from the GCIG member groups has facilitated a collegial approach to international differences and restrictions.One of the powerful initiatives of the GCIG is the facilitation of the Ovarian Cancer Consensus Conference every few years. The 4th Ovarian Cancer Consensus Conference was held in Vancouver, Canada, in June 2010, and the resulting publications (herein) provide an invaluable resource to researchers in the field of gynecologic oncology.